Robertson Centre for Biostatistics

The Robertson Centre for Biostatistics is a specialised biostatistical research centre in Glasgow, Scotland. It is part of the College of Medical, Veterinary and Life Sciences and the Institute of Health and Wellbeing at the University of Glasgow. All scales of research are carried out at the centre from multi-site clinical trials to small scale research projects. The centre also has interests in the development of novel informatics solutions for clinical research, statistical issues in epidemiology and health economic evaluation.[1]

The Robertson Centre for Biostatistics is in the Boyd Orr Building, University of Glasgow, Glasgow, UK, 2007

History

The centre led the WOSCOP study (New England Journal of Medicine 1995; 333:1301-7) which found that treatment with Pravastatin significantly reduced the risk of myocardial infarction and the risk of death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolaemia and no history of myocardial infarction.[2]

The Robertson Centre joined with the Glasgow Clinical Research Facility and Greater Glasgow and Clyde NHS R&D division in November 2007 to create a UKCRN registered Clinical Trials Unit - the Glasgow Clinical Trials Unit.[3]

References
  1. Robertson Centre for Biostatistics, retrieved 4 February 2008
  2. The WOSCOP Study, retrieved 4 February 2008
  3. University Of Glasgow Press Release, retrieved 4 February 2008
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.